To understand the biological mechanisms underlying thousands of genetic variants robustly associated with complex traits, scalable methods that integrate GWAS and functional data generated by largescale efforts are needed. Here we propose a method termed MetaXcan that addresses this need by inferring the downstream consequences of genetically regulated components of molecular traits on complex phenotypes using summary data only. MetaXcan allows multiple causal variants and flexible multivariate models enabling the testing of a variety of complex processes under different contexts. As an example application, we trained prediction models of gene expression levels in 44 human tissues and inferred the consequences of their regulation in 40 complex phenotypes. Our examination of this broad set of human tissues revealed many novel genes and re-identified known ones with patterns of regulation in expected as well as unexpected tissues.
Introduction
Over the last decade, GWAS have been successful in identifying genetic loci that robustly associate with human complex traits. However, the mechanistic understanding of these discoveries is still limited, hampering the translation of this knowledge into actionable targets. Studies of enrichment of expression quantitative trait loci (eQTLs) among trait-associated variants [1] [2] [3] show the importance of gene expression regulation. Direct quantification of the contribution of different functional classes of genetic variants showed that 80% of the common variant contribution to phenotype variability (in 12 diseases) can be attributed to DNAase I hypersensitivity sites, further highlighting the importance of transcript regulation in determining phenotypes [4] .
Many transcriptome studies have been conducted where genotypes and expression levels are assayed for a large number of individuals [5] [6] [7] [8] . The most comprehensive transcriptome dataset, in terms of tissues covered, is the one generated by the Genotype-Tissue Expression Project (GTEx); a large-scale effort where DNA and RNA are collected from multiple tissue samples from nearly 1000 individuals and sequenced to high coverage [9] . This remarkable resource provides a comprehensive cross-tissue survey of the functional consequences of genetic variation at the transcript level.
To integrate knowledge generated from these large-scale transcriptome studies and shed light on disease biology, we developed PrediXcan [10] , a gene-level association approach that tests the mediating effects of gene expression levels on phenotypes. This is implemented on GWAS/sequencing studies (i.e. studies with genome-wide interrogation of DNA variation and phenotypes) where transcriptome levels are imputed with models trained in measured transcriptome datasets (e.g. GTEx). These predicted expression levels are then correlated with the phenotype in a gene-level association test that addresses some of the key limitations of GWAS [10] .
A method based on similar ideas was proposed by Gusev et al. [11] called Transcriptome-wide Association Study (TWAS) . For the individual level data based version, the main difference between PrediXcan and TWAS resides in the models used for the prediction of gene expression levels in the implementa-Zhu et al [15] proposed another method that integrates eQTL data with GWAS results based on summary data. The method, Summary Mendelian Randomization (SMR), uses Wald statistics (effect size/standard error) from GWAS and eQTL studies and derives the effect of the genetic component of gene expression on a phenotype using the delta approximation [16] . By design, this approach uses one eQTL per gene so that in practice only the top eQTL is used per gene.
Here we present a method we call MetaXcan that greatly expands the applicability of the ideas behind PrediXcan by using only summary results. We will show that our method can reproduce PrediXcan results accurately and it is robust to ancestry mismatches between study, reference, and training populations. We also emphasize that given the relatively easy access to summary statistics, MetaXcan allows us to compute the phenotypic consequences of any molecular process that can be approximated by linear functions of SNPs.
To illustrate the power of MetaXcan, we first train over 1 million elastic net prediction models of gene expression traits, covering protein coding genes across 44 human tissues from GTEx, and then apply it to 40 phenotypes from 17 large meta analysis consortia. We use the results of these to lay the groundwork for building a comprehensive catalog of phenotypic consequences of gene regulation across multiple tissues and contexts.
Results

Inferring PrediXcan results with summary statistics
We have derived an analytic expression that allows us to compute the outcome of PrediXcan using only summary statistics from genetic association studies. Details of the derivation are shown in the Methods section. In Figure 1 , we illustrate the mechanics of MetaXcan in relation to traditional GWAS and our recently published PrediXcan method [10] .
For both GWAS and PrediXcan, the input is a genotype matrix and phenotype vector. GWAS computes the regression coefficient of the phenotype on each marker in the genotype matrix and generates SNP-level results. PrediXcan starts by estimating the genetically-regulated component of the transcriptome (using weights from the publicly available PredictDB database) and then computes regression coefficients of the phenotype on each predicted gene expression level generating gene-level results.
MetaXcan, on the other hand, can be viewed as a shortcut that uses the output from a GWAS study 4 to infer the output from PrediXcan. Since MetaXcan only uses summary statistics, it can effectively take advantage of large-scale meta analysis results, avoiding the computational and regulatory burden of handling large amounts of protected individual-level data. Figure 1B shows the main analytic expression used by MetaXcan for the Z-score (Wald statistic) of the association between predicted gene expression and a phenotype. The input variables are the weights used to predict the expression of a given gene, the variance and covariances of the markers included in the prediction of the expression level of the gene, and the GWAS coefficient for each marker. The last factor in the formula can be computed exactly in principle, but we would need additional information that is unavailable in typical GWAS summary statistics output such as sample size and variance of the phenotype.
MetaXcan formula
Dropping this factor from the formula does not affect the accuracy of the results as demonstrated in the close to perfect concordance between MetaXcan and PrediXcan results on the diagonal of Figure 2A .
The approximate formula we use is:
where • w lg is the weight of SNP l in the prediction of the expression of gene g,
•β l is the GWAS regression coefficients for SNP l,
• se(β l ) is standard error ofβ l ,
•σ l is the estimated variance of SNP l, and
•σ g is the estimated variance of the predicted expression of gene g.
The inputs are based, in general, on data from three different sources:
• study set (e.g. GWAS study set),
• training set (e.g. GTEx, DGN),
• population reference set (e.g. 1000 Genomes).
. CC-BY 4.0 International license peer-reviewed) is the author/funder. It is made available under a The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/045260 doi: bioRxiv preprint first posted online Mar. 23, 2016; Figure 1 . A) Comparison of GWAS, PrediXcan, and MetaXcan This figure illustrates the MetaXcan method in relationship to GWAS and PrediXcan. Both GWAS and PrediXcan take genotype and phenotype data as input. GWAS computes the regression coefficients of Y on X l using the model Y = a + X l b + , where Y is the phenotype and X l the individual SNP dosage. The output is the table of SNP-level results. PrediXcan, in contrast, starts first by predicting/imputing the transcriptome. Then it calculates the regression coefficients of the phenotype Y on each gene's predicted expression T g . The output is a table of gene-level results. MetaXcan directly computes the gene-level association results using the output from GWAS. B) MetaXcan formula. This plot shows the formula to infer PrediXcan gene-level association results using summary statistics. The different sets involved in input data are shown. The regression coefficient between the phenotype and the genotype is obtained from the study set. The training set is the reference transcriptome dataset where the prediction models of gene expression levels are trained. The reference set, in general 1000 Genomes, is used to compute the variances and covariances (LD structure) of the markers used in the predicted expression levels. Both the reference set and training set values are pre-computed and provided to the user so that only the study set results need to be provided to the software. The crossed out term was set to 1 as an approximation, since its calculation depends on generally unavailable data. We found this approximation to have negligible impact on the results.
The study set is the main dataset of interest from which the genotype and phenotypes of interest are gathered. The regression coefficients and standard errors are computed based on individual-level data from the study set or a SNP-level meta-analysis of multiple GWAS. Training sets are the reference transcriptome datasets used for the training of the prediction models (GTEx, DGN, Framingham, etc.) thus the weights w lg are computed from this set. Training sets are also used to generate variance and covariances of genetic markers, which will usually be different from the study sets. When individual level data are not available from the training set we use population reference sets such as 1000 Genomes data.
In the most common use scenario, users will need to provide only GWAS results using their study set. The remaining parameters are pre-computed, and download information can be found at the https: //github.com/hakyimlab/MetaXcan resource.
Performance in simulated data
We first compared MetaXcan and PrediXcan using simulated phenotypes generated from a normal distribution, using a single transcriptome model trained on Depression Genes and Network's (DGN) Whole Blood data set [5] downloaded from PredictDB (http://predictdb.org). For genotypes we used three ancestral subsets of the 1000 Genomes project: Africans (n=661), East Asians (n=504), and Europeans (n=503). Each set was taken in turn as reference and study set yielding a total of 9 combinations as shown in Figure 2 . For each population combination, we computed PrediXcan association results for the simulated phenotype and compared them with results generated using MetaXcan in a scatter plot. In this manner we assess the effect of ancestral differences between study and reference sets.
As expected, when the study and reference sets are the same, the concordance between MetaXcan and PrediXcan is 100%, whereas for sets of different ancestral origin the R 2 drops a few percentage points, with the biggest loss (down to 85%) when the study set is African and the reference set is Asian. This confirms that our formula works as expected and that the approach is robust to ethnic differences between study and reference sets.
Performance in cellular growth phenotype from 1000 genomes cell lines
Next we tested with an actual cellular phenotype -intrinsic growth. This phenotype was computed based on multiple growth assays for over 500 cell lines from the 1000 Genomes project [17] . We used a subset of values for European (EUR), African (AFR), and Asian (EAS) individuals. We compared Z-scores for intrinsic growth generated by PrediXcan and MetaXcan for different combinations of reference and study sets, using whole blood prediction models trained in the DGN cohort.
The results are shown in Figure 2B . Consistent with our simulation study, the MetaXcan results closely match the PrediXcan results. Again, the best concordance occurs when reference and study sets share similar continental ancestry while differences in population slightly reduce concordance. Compared to the plots for the simulated phenotypes, the diagonal concordance is slightly lower than 1. This is due to the fact that more individuals were included in the reference set than in the study set, thus the study and reference sets were not identical for MetaXcan.
Performance on disease phenotypes from WTCCC
We show the comparison of MetaXcan and PrediXcan results for two diseases: Bipolar Disorder (BD) and Type 1 Diabetes (T1D) from the WTCCC in Figure 2C . Other disease phenotypes exhibited similar performance (data not shown). Concordance between MetaXcan and PrediXcan is over 99% for both diseases (BD R 2 = 0.996 and T1D R 2 = 0.995). The very small discrepancies are explained by differences in allele frequencies and LD between the reference set (1000 Genomes) and the study set (WTCCC).
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. Next we demonstrate the utility of MetaXcan by training prediction models for a broad set of primary tissue expression levels from GTEx and applying them to multiple GWAMA summary results.
Prediction models across 44 human tissues
Using the release version 6p (dbGaP Accession phs000424.v6.p1) from GTEx, we have trained prediction models for expression levels of 44 human tissues with a total of 1,091,787 gene tissue pairs. Among these 203,494 yielded prediction models with cross validated q value < 0.05 (FDR computed within each tissue model) and corresponding to protein coding genes. These were saved into the publicly available PredictDB database and used for subsequent analysis.
To build the models, we use SNPs within 1Mb upstream of the TSS and 1Mb downstream of the TES. We use elastic net [23] , a multivariate linear model estimated via penalized maximum likelihood, with a mixing parameter of 0.5. As reported in [10, 22] overall performance remains similar for a range of values of the mixing parameter but drops abruptly when the model becomes very close to ridge regression (fully polygenic). Based on this, we chose to use elastic net with 0.5 as mixing parameter, which retains several correlated predictors and is consequently more robust to missing genotype data or low quality imputation. A summary of tissues, sample sizes, and number of attempted and successful models (FDR < 5%) can be found in Supplementary Table 7 .
Catalog of the phenotypic consequences of gene regulation
Next we downloaded summary statistics of meta analysis of 40 phenotypes from 17 consortia. The full list of consortia and phenotypes is shown in Supplementary Table 3. We tested association between these phenotypes and the predicted expression levels using elastic net models in 44 human tissues from GTEx as described in the previous section and a whole blood model from the DGN cohort presented in [10] .
We used a Bonferroni threshold accounting for all the gene-tissue pairs that were tested (0.05/total number of gene-tissue pairs ≈ 2.5e-7). This approach is conservative because the correlation between tissues would make the total number of independent tests smaller than the total number of gene-tissue pairs. Height had the largest number of genes significantly associated with 1691 unique genes (based on a GWAMA of 250K individuals), followed by schizophrenia with 285 unique significant genes (n =
. . .
. . . . . .
or BSLMM weights distribution when the eQTL association is much stronger than the GWAS association, i.e. Z S1,X (eQTL) >> Z S1,Y (GWAS). ImpG [19] and DIST [20] are precursors of TWAS-summary. These impute the summary results of unmeasured SNPs using a Gaussian imputation scheme. The weights are given by the Best Linear Unbiased Prediction (BLUP) formula. TWAS-summary simply extends this idea to imputed gene expression levels but allows use of other weighting scheme such as BSLMM. MetaXcan directly computes the result of PrediXcan using summary statistics only.
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Mostly, genome-wide significant genes tend to cluster around known SNP level genome-wide significant loci or sub-genome wide significant loci. Because of the reduction in multiple testing or an increase in power because it takes into account the combined effects of multiple variants, regions with sub-genomewide significant SNPs can yield genome-wide significant results in MetaXcan. Supplementary Table 2 lists a few examples where this occurs.
As expected, results of MetaXcan tend to be more significant as the genetic component of gene expression increases (larger cross validated prediction performance R 2 ). Similarly, MetaXcan associations tend to be more significant when prediction p-values are more significant. The trend is seen both when results are averaged across all tissues for a given phenotype or across all phenotypes for a given tissue.
All tissues and representative phenotypes are shown in Supplementary Figures 1-4 . This trend was also robust to using different monotone functions of the Z-scores.
The full set of results can be queried in our online catalog (gene2pheno.org). This web application allows filtering the results by gene, phenotype, tissue, p value, and prediction performance . For each trait we assigned ontology terms from the Experimental Factor Ontology (EFO) [24] and Human Phenotype Ontology (HPO) [25] , if applicable. As the catalog grows, the ontology annotation will facilitate the analysis by hierarchy of phenotypes. Supplementary Table 3 shows the list of consortia and phenotypes for which gene level association are available.
Disease associated genes in ClinVar also associated in MetaXcan
We verified that disease genes listed in ClinVar for obesity, rheumatoid arthritis, diabetes, Alzheimer's, Crohn's disease, ulcerative colitis, and age-related macular degeneration [26] show inflated significance among MetaXcan association results for the corresponding diseases. Schizophrenia and autism genes did not show enriched significance, which is not surprising given the highly polygenic nature of these phenotypes and consequently smaller effect sizes of these disease genes. Genes with small effect sizes are likely to be underrepresented in ClinVar. Figure 4 . ClinVar genes show significant MetaXcan associations. Genes implicated in ClinVar tended to be more significant in MetaXcan for most diseases we tested, except for schizophrenia and autism. Blue circles correspond to qqplot of genes in ClinVar that were annotated with the phenotype and black correspond to all genes .
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The broad coverage of tissues in our prediction models enabled us to examine the tissue specificity of phenotypic consequences of GWAS signals. We started by computing average enrichment of significance by tissue. We used several measures of enrichment such as the mean Z-scores squared across all genes, or across significant genes for different thresholds, as well as the proportion of significant genes for different thresholds. We also compared the full distribution of the p-values of a given tissue relative to the remaining tissues. Supplementary Figure 5 shows the average Z-score 2 as a measure of enrichment of each tissue by phenotype.
For low-density lipoprotein cholesterol (LDL-C) levels, liver was the most enriched tissue in significant associations as expected given known biology of this trait. This prominent role of liver was apparent despite the smaller sample size available for building liver models (n=97), which was less than a third of the numbers available for muscle (n=361) or lung (n=278). In general, however, expected tissues for diseases given currently known biology did not stand out as more enriched when we looked at the average across all (significant) genes using various measures of enrichment in our results. For example, the enrichment in liver was less apparent for high-density lipoprotein cholesterol (HDL-C) or triglyceride levels.
Next we focus on a few genes whose functional role has been well established: C4A for schizophrenia [27] and SORT1 [28] and PCSK9 both for LDL-C and cardiovascular disease. The MetaXcan results for these genes and traits and regulatory activity by tissue (as measured by the proportion of expression explained by the genetic component) are shown in Figure 5 and details can be found in Supplementary   Tables 4, 5, and 6 There is strong evidence that SORT1 has a causal role in LDL-C levels which is likely to affect risk for cardiovascular disease. This gene is most actively regulated in liver (close to 50% of the expression level of this gene is determined by the genetic component) with the most significant MetaXcan association in liver (p-value ≈ 0) consistent with our prior knowledge of lipid metabolism.
Other genes are found to be associated across multiple tissues. C4A is one example that was significantly associated with schizophrenia risk across all tissues (p< 10 −7 in 36 tissue models and p<0.05
for the remaining 4 tissue models) even though the effect of this gene is thought to be determined by excessive synaptic pruning in the brain during development.
PCSK9 is a target of several LDL cholesterol lowering drugs currently under trial to lower cardiovac- . [29] . Results from the STARNET study [30] profiled gene expression levels in cardiometabolic disease patients and showed that index SNP rs12740374 to be a strong eQTL for PCSK9 in visceral fat but not in liver. Consistent with this our MetaXcan results also show highly significant association between PCSK9 and LDL cholesterol (p ≈ 10 −13 ) in visceral fat and not in liver (our training algorithm did not yield a prediction model for PCSK9 i.e. there was no evidence of regulatory activity). In our results, however, the statistical evidence is much stronger in tibial nerve (p ≈ 10 −27 ). The association between PCSK9 and coronary artery disease is also significant in tibial nerve (p ≈ 10 −8 ) but only nominally significant in visceral fat (p ≈ 0.02). Accordingly, in our training set (GTEx), there is much stronger evidence of regulation of this gene in tibial nerve compared to visceral fat.
These examples show the importance of studying the regulation in a broad set of tissues and contexts and emphasize the challenges of determining causal tissues of complex traits based on in-silico analysis alone.
Discussion
Here we propose MetaXcan, a method that integrates genetically regulated components of molecular traits into large-scale GWAS results, to gain insight into the mechanisms that link genetic variation to phenotypic variation.
MetaXcan scales up the applicability of ideas behind PrediXcan and allows us to build a mechanism testing framework using prediction models of complex molecular processes and publicly available GWAMA summary results. Any molecular process that can be represented as linear functions of SNP variation can be encoded into prediction models which are in turn used to infer the phenotypic consequences via
MetaXcan. These processes include, for example, expression levels of genes, intron usage, methylation status, telomere length, within different spatial, temporal, and developmental contexts.
As an example application of this framework, we trained transcriptome models in 44 human tissues from GTEx and estimated their effect on phenotypes from multiple publicly available GWAMA studies.
We find known disease and trait associated genes active in relevant tissues but we also discover patterns of regulatory activity in tissues that are not traditionally associated with the trait. Further investigation of context and tissue specificity of these processes is needed but our results emphasize the importance of methods that integrate functional data across a broad set of tissues and contexts to augment our ability .
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To facilitate broad adoption of the MetaXcan framework, we make user-friendly software and all pre-computed prediction models publicly available. We also host MetaXcan results for publicly available GWAMA results and make it freely available to the research community. This database lays the groundwork for a comprehensive catalog of phenome-wide consequences of complex molecular processes.
Software and Resources
We make our software publicly available on a GitHub repository: https://github.com/hakyimlab/ MetaXcan. Prediction model weights and covariances for different tissues can be downloaded from predictdb.org. A short working example can be found on the GitHub page; more extensive documentation can be found on the project's wiki page. The results of MetaXcan applied to the 44 human tissues and a broad set of phenotypes can be queried on gene2pheno.org.
Methods
Derivation of MetaXcan Formula
The goal of MetaXcan is to infer the results of PrediXcan using only GWAS summary statistics. Individual level data are not needed for this algorithm. We will define some notations for the derivation of the analytic expressions of MetaXcan.
Notation and Preliminaries
Y is the n-dimensional vector of phenotype for individuals i = 1, n. X l is the allelic dosage for SNP l.
T g is the predicted expression (or estimated GREx, genetically regulated expression). w lg are weights to predict expression T g = l∈Modelg w lg X l , derived from an independent training set.
We model the phenotype as linear functions of X l and T g
where α 1 and α 2 are intercepts, η and error terms independent of X l and T g , respectively. Letγ g andβ l .
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We will denote as Var and Cov the operators that compute the sample variance and covariance, i.e.
Var(Y ) =σ
) and Γ g = (X −X) (X −X)/n, where X is the n × p matrix of SNP data andX is a n × p matrix where column l has the column mean of X l (p being the number of SNPs in the model for gene g).
With this notation, our goal is to infer PrediXcan results (γ g and its standard error) using only GWAS results (β l and se), estimated variances of SNPs (σ Input:
Next we list the properties and definitions used in the derivation:
The proportion of variance explained by the covariate (T g or X l ) can be expressed as
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where W g is the vector of w lg for SNPs in the model of g
Calculation of regression coefficientγ ĝ γ g can be expressed aŝ
by linearity of Cov
Calculation of standard error ofγ g Also from the properties of linear regression we know that
In this equation,σ 2 Y /n is not necessarily known but can be estimated using the analogous equation (6) for beta
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Calculation of Z score
To assess the significance of the association, we need to compute the ratio of the estimated effect sizeγ g and standard error se(γ g ), or Z score,
with which we can compute the p value as
using Eq. 5 and 6
Based on results with actual and simulated data for realistic effect size ranges, we have found that the last approximation does not affect our ability to identify the association. The approximation becomes inaccurate only when the effect sizes are very large. But in these cases, the small decrease in statistical efficiency induced by the approximation is compensated by the large power to detect the larger effect sizes. Once we fit all models, we retained only the models which reached significance at a False Discovery Rate of less than 0.05. For each tissue examined, we created a sqlite database to store the weights of the prediction models, as well as other statistics regarding model training. These databases have been made available for download at PredictDB.org.
Comparison with TWAS
Formal similarity with TWAS can be made more explicit by rewriting MetaXcan formula in matrix form.
With the following notation and definitions 23, 2016; and correlation matrix of SNPs in the model for gene g
it is quite straightforward to write the numerator in 1 and 12 as
and the denominator, the variance of the predicted expression level of gene g, as
This equation has the same form as the TWAS expression if we use the scaled weight vectorW g instead of W g . TWAS-Summary imputes the Zscore from the gene-level result assuming that under the null the Zscores are normally distributed with the same correlation structure as the SNPs whereas in MetaXcan we compute the result of PrediXcan using summary statistics. In the Methods Section we show that with slightly different reasoning TWAS-summary and MetaXcan yield equivalent mathematica expression (after setting the factor
Comparison with SMR
SMR quantifies the strength of the association between expression levels of a gene and complex traits with T SMR using the following function of the eQTL and GWAS Z-score statistics.
which can be expressed as
GWAS (14)
Here Z eqtl is the Z score (=effect size / standard error) of the association between SNP and gene expression, and Z GWAS is the Z score of the association between SNP and trait. Thus the inverse of the square of the Wald statistic derived by Yang et al is the sum of two inverse χ 2 (Z is asymptotically normally, Z2 is chisquare, 1/Z2 is inverse chisquare). This approximation only holds if the significance of the eQTL is very large so that only the GWAS Z-score contributes to the statistics. So within the range where this approximation is valid
On the other hand the MetaXcan formula when only the top eQTL is used to predict the expression level of a gene is
where Z 1 is the GWAS Z-score of the top eQTL in the model for gene. Thus
SMR will work well if there is no allelic heterogeneity.
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